A comprehensive understanding of this pathway may facilitate research aimed at identifying potential therapeutic targets to modulate the aberrant TNFR2/HIF-1α activity, which is crucial for the treatment of cancers including BC. The gene discussed is TNFRSF1B; the disease is breast cancer.